CX-072
CTMX-M-072-001
Phase 2 small_molecule terminated
Quick answer
CX-072 for Solid Tumor is a Phase 2 program (small_molecule) at CytomX Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CytomX Therapeutics
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated